E-Newsletter
Subscribe Now
  ABOUT US   |   CONTACT US   |   SUBSCRIPTION CENTRE   |   ADVERTISE   |   SITEMAP
MAGAZINE
Current Issue
Past Issues
Digital Magazine
News Archives
Web Exclusives
 
MARKETPLACE
Job Board
Classifieds
Product News
COMMUNITY
Blog
Events
 
RESOURCES
E-Newsletter
Links
Sitemap
 
BioAmber reaches milestone in succinic acid production
October 1, 2013, Minneapolis, Minn. – A significant milestone has been reached in the development of succinic acid producing yeast.

BioAmber has entered into an agreement with Cargill under which BioAmber has exclusively licensed the Cargill yeast technology for succinic acid production. The final milestone in the agreement was for the proprietary yeast to reach performance expectations.

BioAmber has now made their final payment to Cargill as part of the agreement, and will continue work on their 30,000 MT plant in Sarnia, Ontario, which has been engineered to operate with this proprietary yeast. Construction of the facility began in August.

"This milestone achievement is the culmination of three years of joint development with Cargill. We licensed this yeast in 2010 because we strongly believed it is the best technology platform in the industry for making organic acids, and because Cargill has experience in the development and commercialization of organic acids that strengthened our succinic acid program," said Jim Millis, BioAmber's chief technology officer.

"BioAmber and Cargill's collaboration has been successful and our yeast technology has proven effective for making succinic acid. We look forward to BioAmber commercializing the yeast when it brings on line its bio-succinic acid facility in Sarnia," said Gary Folkert, Cargill's biotechnology director of licensing.

"Our proprietary technology platform has been significantly strengthened with the Cargill yeast. This is an important milestone and we plan to continue to work with Cargill to develop alternative feedstock options for our succinic acid platform and to bring to market our adipic acid yeast platform, which we have also licensed exclusively from Cargill," said Jean-Francois Huc, BioAmber's chief executive officer.